Metabolomics Technology Market size, Analysis by Trend and Forecast

The Global Metabolomics Technology Market t is expected to reach $2.39 billion, at a CAGR of 14.6% during the forecast period.

Metabolomics is a powerful and unique analytical approach for the systematic identification and quantification of small-molecule metabolites, metabolite target analysis, metabolic profiling, and metabolic fingerprinting in various biological systems and samples. In addition, manufacturers are increasingly focusing on strengthening their presence in emerging markets of APAC countries.

This Metabolomics Technology Market majorly comprises detection techniques such as mass spectrometry (MS) and nuclear magnetic resonance spectroscopy (NMR), and separation techniques such as gas chromatography.

Download PDF (Metabolomics Market): https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=900

Metabolomics Technology Market segmentation:

· based on product

· based on an indication

· based on service,

· based on regions.

The Major Players Operating in the Metabolomics Technology Market:

The global Metabolomics Technology Market is highly competitive in nature, with the top five companies accounting for the major market share.

These leading players have primarily focused on product launches, acquisitions, agreements, collaborations, partnerships, and expansions for growth in the Metabolomic Market.

Some key players in this market are Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), Shimadzu Corporation (Japan), Metabolon Inc. (U.S.), LECO Corporation (U.S.), Biocrates Life Sciences AG (Austria), Human Metabolome Technologies, Inc. (Japan), and Waters Corporation (U.S.).

Geographical Detailed Analysis for Metabolomics Technology Market:

North America accounted for the largest share of the Metabolomics Technology Market, followed by Europe.

Easy accessibility to technologically advanced products and the presence of many leading metabolomics manufacturers in the region are driving market growth in North America.

Similarly, the rising acceptance of personalized medicines, increasing metabolomics market research activities, and growing adoption of technologically advanced products are driving the growth of the North American Metabolomics Technology Market.

The Asia-Pacific region is expected to witness the highest growth in this market majorly due to improving biopharmaceutical research infrastructure, large population, rising healthcare needs, growing per capita income, and growing economies in Japan and India.

Read More in Detailed (Metabolomics Technology):

https://www.marketsandmarkets.com/Market-Reports/metabolomics-technology-market-900.html

Biobanking Market Analyzed Globally by Top Key Players, Trends, Share, Growth Rate and Forecast

The Biobanking Market is expected to reach USD 2.69 Billion by 2022 from USD 1.85 Billion in 2017, at a CAGR of 7.8%.

The base year for this study is 2016. The Biobanking segment is estimated to account for the largest share of the market in 2017. This is primarily attributed to the increasing number of biobanks and rising number of biosamples around the world, due to which the demand for equipment remains high.

Don’t miss out on business opportunities in Biobanking Market

The equipment segment is expected to dominate the market in 2017

By-product and service, the Biobanking Market have segmented into equipment, consumables, services, and software. The equipment segment is expected to dominate the global Biobanking Market in 2017. Rising number of biobanks and the increasing number of biospecimens are factors increasing the demand for biobanking equipment.

Request Research Sample:https://www.marketsandmarkets.com/requestsampleNew.asp?id=594

Blood products are estimated to command the largest market share in 2017

The Biobanking Market is segmented by sample type into blood products, human tissues, nucleic acids, human waste products, cell lines, and biological fluids. In 2017, the blood products segment is expected to account for the largest share of the biobanking market, by sample type. Rising incidence of blood disorders and the increasing demand for various types of blood products across the globe are driving the growth of this segment.

North America is expected to account for the largest share of the market in 2017

Based on region, the Biobanking Market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America is expected to dominate the Biobanking Market in 2017, this is attributed to factors like increasing research activities in regenerative medicine, cell and gene therapy; growing interest in personalized medicine and biomarker discovery; increasing number of biotechnology and pharmaceutical companies; and rising investments in genomics and proteomics research in the region as compared to other regions.

Download PDF (biobank):https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=594

Key players in the Biobanking Market:

Thermo Fisher Scientific Inc. (U.S.), Tecan Group Ltd. (Switzerland), Qiagen N.V. (Germany), Hamilton Company (U.S.), Brooks Automation (U.S.), TTP Labtech Ltd (U.K.), VWR Corporation (U.S.), Promega Corporation (U.S.), Worthington Industries [(Taylor Wharton, U.S.)], Chart Industries (U.S.), Becton, Dickinson and Company (U.S.), Merck KGaA (Germany)